Agilent Raises Outlook on Q3 Growth
Agilent Technologies(NYSE:A) reported Q3 FY2025 revenue of $1.74 billion, up 6.1% year-over-year on a core basis, with non-GAAP EPS of $1.37, both exceeding guidance. The company raised its full-year revenue outlook to $6.91 billion-$6.93 billion (core growth 4.5% at midpoint), despite higher tariff expenses, driven by robust demand in both Pharma and Chemicals Advanced Materials. Key insights from the earnings call highlight multi-segment growth, margin pressures from tariffs and investment, and a strong innovation pipeline supporting future demand.
Agilent achieved five consecutive quarters of accelerating core revenue growth through Q3 FY2025, with broad-based performance led by double-digit expansion in pharmaceutical and chemicals end markets. The Life Sciences and Diagnostics segment grew 7% core year-over-year, highlighted by mid-teens growth in the Infinity Tree LC platform and over 20% core revenue growth in the NASD contract development and manufacturing organization (CDMO) business.
The company’s ability to accelerate growth across multiple segments and raise guidance, even amid external headwinds, demonstrates strong execution and positions Agilent to capitalize on secular demand trends in its core markets.
Source Fool.com
Agilent Technologies Inc. Stock
With 14 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 127 € shows a slightly positive potential of 7.48% compared to the current price of 118.16 € for Agilent Technologies Inc..
